EMVision Medical Devices Ltd (EMV.AX)
AUD 1.84
(-2.13%)
AUD 1.84
(-2.13%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 11.21 Million AUD | 69.19% |
| 2023 | 6.63 Million AUD | 61.07% |
| 2022 | 4.11 Million AUD | 159.76% |
| 2021 | 1.58 Million AUD | 2.16% |
| 2020 | 1.55 Million AUD | 9.69% |
| 2019 | 1.41 Million AUD | 187.1% |
| 2018 | 492.66 Thousand AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q4 | 4.36 Million AUD | 0.0% |
| 2024 FY | -410.58 Thousand AUD | -106.19% |
| 2024 Q2 | 6.44 Million AUD | 0.0% |
| 2023 Q2 | 4.79 Million AUD | 0.0% |
| 2023 FY | 6.63 Million AUD | 61.07% |
| 2023 Q4 | 1.83 Million AUD | 0.0% |
| 2022 FY | 4.11 Million AUD | 159.76% |
| 2022 Q2 | 3.31 Million AUD | 0.0% |
| 2022 Q4 | 799.36 Thousand AUD | 0.0% |
| 2021 Q2 | 1.62 Million AUD | 0.0% |
| 2021 FY | 1.58 Million AUD | 2.16% |
| 2021 Q4 | -44.24 Thousand AUD | 0.0% |
| 2020 FY | 1.55 Million AUD | 9.69% |
| 2020 Q4 | 427.35 Thousand AUD | 0.0% |
| 2020 Q2 | 1.12 Million AUD | 0.0% |
| 2019 Q4 | 738.78 Thousand AUD | 0.0% |
| 2019 Q3 | - AUD | -100.0% |
| 2019 Q2 | 675.65 Thousand AUD | 0.0% |
| 2019 FY | 1.41 Million AUD | 187.1% |
| 2018 Q2 | - AUD | 0.0% |
| 2018 FY | 492.66 Thousand AUD | 0.0% |
| 2018 Q1 | - AUD | 0.0% |
| 2018 Q4 | 492.66 Thousand AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| 4DMedical Limited | 3.51 Million AUD | -218.95% |
| Adherium Limited | -640.83 Thousand AUD | 1850.716% |
| Aroa Biosurgery Limited | 53.98 Million AUD | 79.219% |
| Atomo Diagnostics Limited | 1.43 Million AUD | -680.898% |
| Anteris Technologies Ltd | 2.51 Million AUD | -345.705% |
| Control Bionics Limited | 3.67 Million AUD | -205.469% |
| CardieX Limited | 10.1 Million AUD | -10.996% |
| Compumedics Limited | 26.06 Million AUD | 56.962% |
| Cochlear Limited | 1.69 Billion AUD | 99.339% |
| CleanSpace Holdings Limited | 11.35 Million AUD | 1.233% |
| Cyclopharm Limited | 4.49 Million AUD | -149.464% |
| Nova Eye Medical Limited | 20.19 Million AUD | 44.44% |
| HeraMED Limited | -504.09 Thousand AUD | 2325.613% |
| Imricor Medical Systems, Inc. | -1.99 Million AUD | 662.961% |
| ImpediMed Limited | 9 Million AUD | -24.589% |
| InhaleRx Limited | 1.2 Million AUD | -831.792% |
| LBT Innovations Limited | -2.91 Million AUD | 484.614% |
| Micro-X Limited | 5.73 Million AUD | -95.559% |
| Neurotech International Limited | -5867.00 AUD | 191325.567% |
| OncoSil Medical Limited | 55.63 Thousand AUD | -20066.818% |
| PolyNovo Limited | 36.08 Million AUD | 68.909% |
| Respiri Limited | 456.91 Thousand AUD | -2355.43% |
| SomnoMed Limited | 55.13 Million AUD | 79.65% |
| Universal Biosensors, Inc. | 4.28 Million AUD | -161.829% |
| Uscom Limited | 3.11 Million AUD | -260.087% |
| Visioneering Technologies, Inc. | -271.11 Thousand AUD | 4238.156% |